T cell receptor (on CD4-positive helper T cell) (TCR (on CD4^+ T cell))

The **T cell receptor (TCR) on CD4-positive helper T cells** is a multi-subunit protein complex on the surface of CD4^+ T lymphocytes, responsible for recognizing peptide antigens presented by major histocompatibility complex class II (MHC II) molecules on antigen-presenting cells. The TCR is composed of heterodimeric α and β chains (most commonly for helper T cells), associated with invariant CD3 subunits required for signaling. Engagement of the TCR by a cognate peptide-MHC II complex, together with the CD4 coreceptor and costimulatory signals, triggers signal transduction cascades that activate the T cell, leading to cytokine production, proliferation, and differentiation into effector subsets. This process is central to the adaptive immune response, playing roles in infection control, anti-tumor immunity, and the development of autoimmunity[2][4][6][7][8]. The TCR on CD4^+ T cells is not usually a direct drug target, but components of the TCR-CD3 complex are targeted in some immunosuppressive and experimental immunotherapeutic interventions. **Note:** The TCR is present on all T cells, with specificity for CD4^+ helper T cells determined by co-expression of the CD4 coreceptor and recognition of MHC II (as opposed to CD8^+ T cells, which recognize MHC I). Canonical designation for structural/therapeutic purposes is simply “T cell receptor (TCR),” with coreceptor context specified as needed[4][5][6][7][8].

Other names

TCR (on CD4^+ T cell)αβ T cell receptor (on helper T cell)CD4^+ T cell receptorTCR-CD3 complex (on helper T cell)

TCR antagonists can block antigen-specific responses; Anti-CD3 antibodies modulate TCR signaling and induce cell deletion or immunomodulation; Peptide-MHC complexes used in tolerance or redirection approaches